Nimrata Hunt Idexx Laboratories Inc (IDXX) insider trading activity

Nimrata Hunt is Executive Vice President of IDEXX LABORATORIES INC . Currently has a direct ownership of 18,032 shares of IDXX, which is worth approximately $11.5 Million. The most recent transaction as insider was on Aug 12, 2025, when has been sold 1,226 shares (Common Stock) at a price of $309.76 per share, resulting in proceeds of $379,765. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18K

46.28% 3M change

54.44% 12M change

Total Value Held $11.5 Million

Nimrata Hunt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2025	BUY Exercise of conversion of derivative security	$379,765 $309.76 p/Share	1,226 Added 6.37%	18,032 Common Stock
Aug 11 2025	SELL Open market or private sale	$787,836 $656.53 p/Share	1,200 Reduced 6.66%	16,806 Common Stock
Aug 06 2025	SELL Open market or private sale	$4,503,590 $630.49 p/Share	7,143 Reduced 28.4%	18,006 Common Stock
Aug 06 2025	BUY Exercise of conversion of derivative security	$2,246,626 $175.6 p/Share	12,794 Added 33.72%	25,149 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$119,134 $444.53 p/Share	268 Reduced 2.13%	12,327 Common Stock
Feb 14 2025	BUY Exercise of conversion of derivative security	-	872 Added 6.48%	12,595 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$147,427 $560.56 p/Share	263 Reduced 2.2%	11,676 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	208 Added 1.71%	11,939 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	664 Added 5.36%	11,731 Common Stock
Feb 14 2023	SELL Payment of exercise price or tax liability	$120,372 $503.65 p/Share	239 Reduced 2.12%	11,015 Common Stock
Feb 14 2023	BUY Exercise of conversion of derivative security	-	791 Added 6.57%	11,254 Common Stock
Feb 09 2023	BUY Exercise of conversion of derivative security	$99,969 $141.6 p/Share	706 Added 6.32%	10,463 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$103,128 $505.53 p/Share	204 Reduced 2.06%	9,702 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	-	675 Added 6.38%	9,906 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$115,831 $104.73 p/Share	1,106 Added 10.72%	9,212 Common Stock
Aug 05 2021	SELL Open market or private sale	$378,214 $703.0 p/Share	538 Reduced 6.22%	8,106 Common Stock
Aug 05 2021	BUY Exercise of conversion of derivative security	$56,345 $104.73 p/Share	538 Added 5.86%	8,644 Common Stock
Feb 14 2021	SELL Payment of exercise price or tax liability	$117,521 $544.08 p/Share	216 Reduced 2.6%	8,083 Common Stock
Feb 14 2021	BUY Exercise of conversion of derivative security	-	714 Added 7.92%	8,299 Common Stock
Nov 05 2020	SELL Open market or private sale	$986,228 $470.08 p/Share	2,098 Reduced 21.7%	7,571 Common Stock

Also insider at

VEEV

VEEVA SYSTEMS INC Healthcare

Director

Nimrata Hunt

Executive Vice President

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDXX shares.

Notify only if

Value

Insider Trading

Get notified when an Idexx Laboratories Inc insider buys or sells IDXX shares.

Notify only if

Operation

Value

Type

News

Receive news related to IDEXX LABORATORIES INC

Track Activities on IDXX

Account